Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®, the first and only trifocal IOL that combines patented enhanced Sinusoidal Vision Technology…

What is Diffuse Lamellar Keratitis (DLK)? Diffuse Lamellar Keratitis, commonly referred to as DLK, is an inflammatory condition that can occur following LASIK (Laser-Assisted In Situ Keratomileusis) eye surgery. DLK is characterized by inflammation in the corneal flap, which is…

What Is Ocular Toxoplasmosis? Ocular toxoplasmosis is an eye infection caused by the Toxoplasma gondii parasite. It is a form of toxoplasmosis that specifically affects the eyes, often leading to inflammation of the retina, and potentially causing vision problems, including…

Light Adjustable Lens (LAL) technology is a groundbreaking advancement in the field of ophthalmology, offering a novel approach to vision correction and the treatment of cataracts. Unlike traditional intraocular lenses that are permanently fixed in their refractive power, LALs can…

What Is Corneal Clouding? Corneal clouding, also known as corneal opacity, refers to a loss of transparency in the cornea, the clear front surface of the eye that allows light to enter and helps in focusing it onto the retina.…

Novartis has officially completed the divestment of its ‘front of eye’ ophthalmology assets to Bausch + Lomb. The transaction is valued at up to USD 2.5 billion, which includes an upfront cash payment of 1.75 billion dollars, along with potential…
In a proactive measure to contain a rapidly spreading eye virus, Pakistani authorities have announced the temporary closure of more than 56,000 schools across the nation. The decision comes as health officials grapple with a surge in cases of a…

Ocuphire Pharma and Viatris announced that the FDA has granted approval for Ryzumvi (phentolamine ophthalmic solution) 0.75%. This approval specifically authorizes its use in the treatment of pharmacologically-induced mydriasis, produced by adrenergic agonists (such as phenylephrine) or parasympatholytic agents (like…

Thea Pharma announced the launch and availability of Iyuzeh (latanoprost ophthalmic solution) 0.005% in the United States market. Iyuzeh, having obtained FDA approval in December 2022, stands as the first preservative-free latanoprost product for individuals in the US diagnosed with…

What Is Radial Keratotomy? Radial Keratotomy (RK) stands as a significant milestone in the evolution of vision correction surgeries. This procedure, introduced in the 1970s, paved the way for modern refractive surgeries. This comprehensive article aims to provide an in-depth…